Выход
Вход/Login
 
E-mail
Пароль/Password
Забыли пароль?
Введите E-mail и жмите тут. Пароль будет выслан на указанный адрес
Войти (LogIn)

 

Если вы первый раз здесь, то зарегистрируйтесь

Регистрация/Sign Up
Полное имя (Ф.И.О.)/Name
E-mail
Телефон/Phone
Зарегистрироваться,
на ваш E-mail будет выслан временный пароль

 

Медицинская литература. Новинки


 

 

 

 

 
вce журналы << Анналы хирургической гепатологии << 2012 год << №3 <<
стр.40
отметить
статью

Резекции печени при метастатических опухолях (лекция)

Н. Кокудо, Й. Кавагучи
Вы можете загрузить полный текст статьи в формате pdf
Норихиро Кокудо (Norihiro Kokudo) – проф., зав. отделением хирургии печени и поджелудочной железы отдела хирургии, Школа последипломного образования Токийского университета (Япония). Йошикуни Кавагучи (Yoshikuni Kawaguchi) – врачхирург того же отделения
Адрес для корреспонденции: 7-3-1-Hongo, Bunkyo-ku, Tokyo, Japan, 113-8655. Тел.: +81-3-5800-8841. Факс:+81-3-5684-3989. E-mail: KOKUDO-2SU@h.u-tokyo.ac.jp

Ключевые слова:

Литература:
1. Weiss L., Grundmann E., Torhorst J. Haematogenous metastatic
patterns in colonic carcinoma: an analysis of 1541 necropsies //
J. Pathol. 1986. V. 150. P. 195–203.
2. Le Treut Y.P., Delpero J.R., Dousset B. et al. Results of liver transplantation in the treatment of metastatic neuroendocrine
tumors. A 31case French multicenter report // Ann. Surg. 1997.
V. 225. P. 355–364.
3. Sakamoto Y., Oyyama S., Yamamoto J. et al. Surgical resection of
liver metastases of gastric cancer: an analysis of a 17year experience with 22 patients // Surgery. 2003. V. 133. P. 507–511.
4. NCCN guidelines in oncology. Breast cancer, version 1.2009.
http://www.nccn.org.
5. Japanese Breast Cancer Society. Histological classification of
breast tumor. In: General Rules for Clinical and Pathological
Recording of Breast Cancer, 16th edn. Tokyo: Kanehara, 2008.
6. Sakamoto Y., Yamamoto J., Yoshimoto Y. et al. Hepatic resection
for metastatic breast сancer: prognostic analysis of 34 patients //
Wld Journal of Surgery. 2005. V. 29. P. 524–527.
7. Adam R., Aloia T., Krissat J. et al. Is liver resection justified for
patients with hepatic metastases from breast cancer? // Ann.
Surg. 2006. V. 244. P. 897–907.
8. Mise Y., Imamura H., Hashimoto T. et al. Cohort study of the survival benefit of resection for recurrence hepatic and/or pulmonary metastases after primary hepatectomy for colorectal
metastases // Ann. Surg. 2010. V. 251. P. 902–909.
9. Adams R.B., Haller D.G., Roh M.S. Improving respectability o
fhepatic colorectal metastases: expert consensus statement //
Ann. Surg. Oncol. 2006. V. 13. P. 1271–1280.
10. Mulier S., Ruers T., Jamart J. et al. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for
a randomized trial? // Anupdate. Dig. Surg. 2008. V. 25.
P. 445–460.
11. Wilson S.M., Adson M.A. Surgical treatment of hepatic metastases from colorectal cancers // Arch. Surg. 1976. V. 111.
P. 330–334.
12. Wagner J.S., Adson M.A., Van Heerden J.A. et al. The natural his
tory of hepatic metastases from colorectal cancer: a comparison
with respective treatment // Ann. Surg. 1984. V. 199. P. 502–508.
13. Abdalla E.K., Vauthey J.N., Ellis L.M. et al. Recurrence and out
comes following hepatic resection, radiofrequency ablation, and
combinedr esection/ablation for colorectal liver metastases //
Ann. Surg. 2004. V. 239. P. 818–825.
14. Japanese Society for Cancer of the Colon and Rectum (JSCCR).
JSCCR guidelines for the treatment of colorectal cancer. Tokyo:
Kanehara, 2010.
15. Kokudo N., Imamura H., Sugawara Y. et al. Surgery for multiple
hepatic colorectal metastases // J. Hepatobil. Pancreat. Surg.
2004. V. 11. N 12. P. 84–91.
16. Makuuchi M., Kosuge T., Takayama T. et al. Surgery for small
liver cancers // Semin. Surg. Oncol. 1993 V. 9. P. 298–304.
17. Saito S., Yamanaka J., Miura K. et al. A novel 3D hepatectomy
simulation based on liver circulation: application to liver resection
and transplantation // Hepatology. 2005. V. 41. P. 1297–1304.
18. Kubota K., Makuuchi M., Kusaka K. et al. Measurement of liver
volume and hepatic functional reserve as a guide to decisionmaking in resectional surgery for hepatic tumors // Hepatorogy.
1997. V. 26. P. 1176–1181.
19. Kawasaki S., Makuuchi M., Kakazu T. et al. Resection for multiple metastatic liver tumors after portal embolization // Surgery.
1994. V. 115. P. 674–677.
20. Fernandez F.G., Ritter J., Goodwin J.W. et al. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment
on respectability of hepatic colorectal metastases // J. Am. Coll.
Surg. 2005. V. 200. P. 845–853.
21. Nakano H., Oussoultzoglou E., Rosso E. et al. Sinusoidal injury
increases morbidity after major hepatectomy in patients with
colorectal liver metastases receiving preoperative chemotherapy
// Ann. Surg. 2008. P. 247. P. 118–124.
22. Vauthey J.N., Pawlik T.M., Ribero D. et al. Chemotherapy regimen predicts steatohepatitis and an increasing 90day mortality
after surgery for hepatic colorectal metastases // J. Clin. Oncol.
2006. V. 24. P. 2065–2072.
23. Minagawa M., Makuuchi M., Torzilli G. et al. Extension of the
frontiers of surgical indications in the treatment of liver metastases from colorectal cancer longtermresults // Ann. Surg. 2000.
V. 231. P. 487–499.
24. Kato T., Yasui K., Hirai T. et al. Therapeutic results for hepatic
metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for
763 cases recorded at 18 institutions // Dis. Colon. Rectum.
2003. V. 46. P. S22–31.
25. Pawlik T.M., Scoggins C.R., Zorzi D. et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases // Ann. Surg. 2005. V. 241.
P. 715–722.
26. André T., Boni C., Mounedji&Boudiaf L. et al. Multicenter
International Study of Oxaliplatin/5Fluorouracil/ Leucovorininthe Adjuvant Treatment of Colon Cancer (MOSAIC)
Investigators. Oxaliplatin, fluorouracil, andl eucovorin as adjuvant treatment for colon cancer // N. Engl. J. Med. 2004. V. 350.
P. 2343–2351.
27. Kuebler J.P., Wieand H.S., O’Connell M.J. et al. Oxaliplatin
combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer:
results from NSABP C07 // J. Clin. Oncol. 2007. V. 25.
P. 2198–2204.
28. Nordlinger B., Sorbye H., Glimelius B. et al. Perioperative
chemotherapy with FOFOX4 and surgery versus surgery alone
for resectable liver metastases fromc olorectal cancer (EORTC
Inter group trial 40983): a randomized controlled trial // Lancet.
2008. V. 371. P. 1007–2008.
29. Nordlinger B., VanCutsem E., GruenbergerT. et al. European
Colorectal Metastases Treatment Groups; Six International
Colorectal Liver Metastases Workshop. Combination of surgery
and chemotherapy and the role of targeted agents in the treatment
of patients with colorectal liver metastases: recommendations
from an expert panel // Ann. Oncol. 2009. V. 20. P. 985–992.
30. Abdalla E.K., Vauthey J.N., Ellis L.M. et al. Recurrence and out
comes following hepatic resection, radiofrequency ablation, and
combined resection/ablation for colorectal liver metastases //
Ann. Surg. 2004. V. 239. P.818–825.
31. Aloia T.A., Vauthey J.N., Loyer E.M. et al. Solitary colorectal
liver metastasis: resection determines outcome // Arch. Surg.
2006. V. 141. P. 460–466.
32. Abitabile P., Hartl U., Lange J. et al. Radiofrequency ablation
permits an effective treatment for colorectal liver metastasis //
Eur. J. Surg. Oncol. 2007. V. 33. P. 67–71.
33. van Duijnhoven F.H., Jansen M.C., Junggeburt J.M. et al. Factors
influencing the local failure rate of radiofrequency ablation of
colorectal liver metastases // Ann. Surg. Oncol. 2006. V. 13.
P. 651–658.
34. Veltri A., Sacchetto P., Tosetti I. et al. Radiofrequency ablation of
colorectal liver metastases: small size favorably predicts technique effectiveness and survival // Cardiovasc. Intervent. Radiol.
2008. V. 31. P. 948–956.

Keywords:

Новости   Магазин   Журналы   Контакты   Правила   Доставка   О компании  
ООО Издательский дом ВИДАР-М, 2016